Optimizing the benefits of BCMA-targeted CAR T-cell therapy in multiple myeloma.

Authors	Sagar Lonial
Journal	Clinical advances in hematology & oncology : H&O (Clin Adv Hematol Oncol) Vol. 21 Issue 1 Pg. 43-45 (01 2023) ISSN: 1543-0790 [Print] United States
PMID	36638355 (Publication Type: Interview)
Chemical References	B-Cell Maturation Antigen Receptors, Chimeric Antigen
Topics	Humans Multiple Myeloma (therapy) Immunotherapy, Adoptive (adverse effects) B-Cell Maturation Antigen Receptors, Chimeric Antigen (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!